QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Genius Sports Limited stock logo
GENI
Genius Sports
$5.13
+0.4%
$6.24
$3.55
$8.45
$1.19B1.962.28 million shs649,971 shs
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
C$0.40
+∞
C$0.40
C$0.30
C$0.56
C$15.51MN/A21,517 shs8,500 shs
LexaGene Holdings Inc. stock logo
LXG
LexaGene
C$0.11
-19.2%
C$0.11
C$0.07
C$0.31
C$14.77M2.26170,061 shs2.14 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Genius Sports Limited stock logo
GENI
Genius Sports
-2.94%-8.58%-10.26%-15.66%+18.13%
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
0.00%0.00%0.00%0.00%0.00%
LexaGene Holdings Inc. stock logo
LXG
LexaGene
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Genius Sports Limited stock logo
GENI
Genius Sports
3.4495 of 5 stars
4.54.00.00.01.82.50.6
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Genius Sports Limited stock logo
GENI
Genius Sports
3.00
Buy$9.2580.31% Upside
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/AN/AN/AN/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/A

Current Analyst Ratings

Latest GDR, GENI, LMD, ABDX, and LXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2024
Genius Sports Limited stock logo
GENI
Genius Sports
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$7.50
4/5/2024
Genius Sports Limited stock logo
GENI
Genius Sports
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$9.00
4/4/2024
Genius Sports Limited stock logo
GENI
Genius Sports
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$10.00
3/7/2024
Genius Sports Limited stock logo
GENI
Genius Sports
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$8.00
3/7/2024
Genius Sports Limited stock logo
GENI
Genius Sports
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
3/6/2024
Genius Sports Limited stock logo
GENI
Genius Sports
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
2/26/2024
Genius Sports Limited stock logo
GENI
Genius Sports
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$8.00
1/19/2024
Genius Sports Limited stock logo
GENI
Genius Sports
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Genius Sports Limited stock logo
GENI
Genius Sports
$412.98M2.89$0.02 per share305.45$2.47 per share2.08
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
C$14.96M1.04C$0.07 per share5.56C$0.10 per share4.08
LexaGene Holdings Inc. stock logo
LXG
LexaGene
C$110.93K133.13C$0.00 per share21.25C$0.01 per share10.50

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Genius Sports Limited stock logo
GENI
Genius Sports
-$85.53M-$0.40N/AN/AN/A-20.71%-12.67%-9.67%5/14/2024 (Estimated)
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/A-C$0.04N/AN/AN/AN/AN/AN/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
-C$8.54M-C$0.08N/AN/AN/A-339.54%-120.21%N/A

Latest GDR, GENI, LMD, ABDX, and LXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/6/202412/31/2023
Genius Sports Limited stock logo
GENI
Genius Sports
-$0.07-$0.17-$0.10-$0.07$126.53 million$127.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Genius Sports Limited stock logo
GENI
Genius Sports
N/AN/AN/AN/AN/A
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/AN/AN/AN/AN/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Genius Sports Limited stock logo
GENI
Genius Sports
N/A
1.34
1.34
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
221.26
1.32
1.03
LexaGene Holdings Inc. stock logo
LXG
LexaGene
138.01
1.39
1.13

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Genius Sports Limited stock logo
GENI
Genius Sports
81.91%
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
0.09%

Insider Ownership

CompanyInsider Ownership
Genius Sports Limited stock logo
GENI
Genius Sports
16.60%
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
N/A
LexaGene Holdings Inc. stock logo
LXG
LexaGene
17.85%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Genius Sports Limited stock logo
GENI
Genius Sports
2,300232.36 million193.79 millionOptionable
LED Medical Diagnostics Inc stock logo
LMD
LED Medical Diagnostics
4638.79 millionN/ANot Optionable
LexaGene Holdings Inc. stock logo
LXG
LexaGene
41140.64 millionN/ANot Optionable

GDR, GENI, LMD, ABDX, and LXG Headlines

SourceHeadline
Pamapol Ord Share Price (0LXG)Pamapol Ord Share Price (0LXG)
lse.co.uk - April 9 at 4:12 PM
Biosynex SA ALBIOBiosynex SA ALBIO
morningstar.com - November 12 at 11:42 AM
Cyclopharm Ltd CYCCyclopharm Ltd CYC
morningstar.com - October 31 at 2:22 PM
Lexagene Holdings Inc (LXGh)Lexagene Holdings Inc (LXGh)
investing.com - October 16 at 8:52 AM
Luang Namtha Airport, Luang Namtha, Laos [ LXG / VLLN ]Luang Namtha Airport, Luang Namtha, Laos [ LXG / VLLN ]
prokerala.com - September 15 at 4:50 PM
Eurobio Scientific Bearer and/or Registered shares issued from reverse spliEurobio Scientific Bearer and/or Registered shares issued from reverse spli
morningstar.com - September 2 at 1:48 AM
Zhejiang Gongdong Medical Technology Co Ltd Class AZhejiang Gongdong Medical Technology Co Ltd Class A
morningstar.com - July 28 at 2:20 PM
Global Food Pathogen Detection Technology Market Research ... - The Northwestern ExaminerGlobal Food Pathogen Detection Technology Market Research ... - The Northwestern Examiner
news.google.com - May 7 at 8:15 AM
NA Food Pathogen Testing Market Size, Share, Industry, Forecast to 2029 - openPRNA Food Pathogen Testing Market Size, Share, Industry, Forecast to 2029 - openPR
news.google.com - May 5 at 5:16 PM
Global Point of Care (PoC) Molecular Diagnostics Market Research ... - Yahoo FinanceGlobal Point of Care (PoC) Molecular Diagnostics Market Research ... - Yahoo Finance
news.google.com - May 4 at 8:53 AM
Pathogen Detection System Market 2023-2029 : COVID-19 Impact ... - Industry TodayPathogen Detection System Market 2023-2029 : COVID-19 Impact ... - Industry Today
news.google.com - April 25 at 9:26 AM
Food Pathogen Testing Market Size, Industry Trends, Business Opportunities, Strategies, Key Players Analysis, - openPRFood Pathogen Testing Market Size, Industry Trends, Business Opportunities, Strategies, Key Players Analysis, - openPR
news.google.com - April 14 at 1:27 PM
Bacterial Diagnostics in Aquaculture Professional Market 2031 ... - The SEM WeeklyBacterial Diagnostics in Aquaculture Professional Market 2031 ... - The SEM Weekly
news.google.com - April 13 at 10:43 AM
Aquaculture Bacterial Diagnosis Market 2031 Business Insights with ... - The SEM WeeklyAquaculture Bacterial Diagnosis Market 2031 Business Insights with ... - The SEM Weekly
news.google.com - April 10 at 6:49 PM
Bacterial Diagnostics in Aquaculture Market 2023 With Top Key ... - Digital JournalBacterial Diagnostics in Aquaculture Market 2023 With Top Key ... - Digital Journal
news.google.com - April 10 at 8:48 AM
Bacterial Diagnostics in Aquaculture Market Size Giants Spending Is Going To Boom | Aquasol Corporation, Ziva - openPRBacterial Diagnostics in Aquaculture Market Size Giants Spending Is Going To Boom | Aquasol Corporation, Ziva - openPR
news.google.com - April 5 at 8:44 PM
Food Pathogen Testing Market Is Expected to Grow at a Highest CAGR of 8.0% Size, Share, Growth Statistics, Eme - openPRFood Pathogen Testing Market Is Expected to Grow at a Highest CAGR of 8.0% Size, Share, Growth Statistics, Eme - openPR
news.google.com - April 3 at 12:22 PM
enCore Energys NRC Source Materials License for Dewey-Burdock Project Now Final and Effective - Investing News NetworkenCore Energy's NRC Source Materials License for Dewey-Burdock Project Now Final and Effective - Investing News Network
news.google.com - March 20 at 2:35 PM
Traction Uranium Commences Key Lake South Phase 1 Diamond Drill Program - Investing News NetworkTraction Uranium Commences Key Lake South Phase 1 Diamond Drill Program - Investing News Network
news.google.com - March 8 at 9:54 AM
Global COVID-19 Diagnostics Market 2023: Assay Volumes and 5 ... - Tullahoma News and GuardianGlobal COVID-19 Diagnostics Market 2023: Assay Volumes and 5 ... - Tullahoma News and Guardian
news.google.com - March 2 at 8:30 AM
Beverly biotech company closes, files for bankruptcy | News ... - The Salem NewsBeverly biotech company closes, files for bankruptcy | News ... - The Salem News
news.google.com - February 28 at 7:34 AM
LexaGene Files for Chapter 7 Bankruptcy - Montreal GazetteLexaGene Files for Chapter 7 Bankruptcy - Montreal Gazette
news.google.com - February 24 at 3:44 PM
LexaGene Files for Chapter 7 Bankruptcy - 360DxLexaGene Files for Chapter 7 Bankruptcy - 360Dx
news.google.com - February 24 at 3:44 PM
Molecular Diagnostics Business LexaGene Seeks Liquidation - Bloomberg LawMolecular Diagnostics Business LexaGene Seeks Liquidation - Bloomberg Law
news.google.com - February 24 at 3:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Genius Sports logo

Genius Sports

NYSE:GENI
Genius Sports Limited engages in the development and sale of technology-led products and services to the sports, sports betting, and sports media industries. It offers technology infrastructure for the collection, integration, and distribution of live data of sports leagues; streaming solutions comprising technology, automatic production, and distribution for sports to commercialize video footage of their games; and end-to-end integrity services to sports leagues, such as full-time active monitoring technology, which uses mathematical algorithms to identify and flag suspicious betting activity in global betting markets, as well as a full suite of online and offline educational and consultancy services. The company also provides live sports data collection; pre-game and in-game odds feeds; risk management services, including customer profiling, monitoring of incoming bets, automated acceptance and rejection of bets, and limit setting; live streaming services; creation, delivery, and optimization of digital marketing campaigns, such as data-driven personalized ad creative; and fan engagement widgets for digital publishers that offer live game statistics and betting-related content. The company is headquartered in London, the United Kingdom.
LED Medical Diagnostics logo

LED Medical Diagnostics

CVE:LMD
LED Medical Diagnostics Inc. develops and markets diagnostic dental imaging products and software in North America. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and VELscope and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides XrayVision DICOM Capture View (DCV), a dental imaging suite to capture, storage, retrieve, and view images across an entire organization; XV4 Mobile for patient follow-up and emergency use in the operating room, remote or mobile clinic, or at home; XVWeb, a Web application that allows an organization to view their images from various Web-enabled devices; and XrayVision, an open-architecture digital image management program. In addition, it offers XV Sync that enables automatic synchronization of various databases for a dental practice; DataGrabber, which allows a customer to bridge patient information from various patient management software packages to a customer's digital imaging software; DCV Data Manager, a picture archive and communication system server application; and XVLite, an open architecture digital dental x-ray software package for capturing, enhancing, and displaying dental images. Further, the company provides data mapping and database conversion services; intraoral digital radiographic sensors under the Tuxedo name; intraoral cameras; and 3D imagining hardware products under the RAYSCAN name. It serves dentists and oral health specialists. LED Medical Diagnostics Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
LexaGene logo

LexaGene

CVE:LXG
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.